Last reviewed · How we verify
BICX104 naltrexone implantable pellet — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
BICX104 naltrexone implantable pellet (BICX104 naltrexone implantable pellet) — BioCorRx Pharmaceuticals Inc.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| BICX104 naltrexone implantable pellet TARGET | BICX104 naltrexone implantable pellet | BioCorRx Pharmaceuticals Inc | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- BICX104 naltrexone implantable pellet CI watch — RSS
- BICX104 naltrexone implantable pellet CI watch — Atom
- BICX104 naltrexone implantable pellet CI watch — JSON
- BICX104 naltrexone implantable pellet alone — RSS
Cite this brief
Drug Landscape (2026). BICX104 naltrexone implantable pellet — Competitive Intelligence Brief. https://druglandscape.com/ci/bicx104-naltrexone-implantable-pellet. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab